Moreover, high concentrations of CKb11, TNF-α and IFN-γ were detected in tumors and ascites without significant changes in CKb11, TNF-α, IFN-γ levels in the serum, indicating locally activated anti-tumor immunity without obvious systemic inflammation responses. The gene discussed is CCL19; the disease is neoplasm.